Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
December 11, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
November 29, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
November 14, 2023 16:05 ET
|
Vivos Therapeutics, Inc
Operating Expenses Decreased 32% Year Over Year and 19% Sequentially as Cost Cutting Measures Take Hold New Strategic Relationships, Including U.S. Nationwide Distribution Agreement with Lincare,...
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
November 09, 2023 16:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Closes $4 Million Private Placement
November 02, 2023 17:00 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
October 31, 2023 08:00 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Reverse Stock Split
October 26, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
October 24, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS a leading medical technology company focused on developing innovative treatments...
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine
October 11, 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company") (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
October 05, 2023 07:30 ET
|
Vivos Therapeutics, Inc
Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company Subject to Regulatory Approvals, Vivos Could See Revenue From This Collaboration in 2024 LITTLETON,...